Literature DB >> 19786571

Changes in retinoblastoma cell adhesion associated with optic nerve invasion.

Nikia Laurie1, Adithi Mohan, Justina McEvoy, Damon Reed, Jiakun Zhang, Brett Schweers, Itsuki Ajioka, Virginia Valentine, Dianna Johnson, David Ellison, Michael A Dyer.   

Abstract

In the 1970s, several human retinoblastoma cell lines were developed from cultures of primary tumors. As the human retinoblastoma cell lines were established in culture, growth properties and changes in cell adhesion were described. Those changes correlated with the ability of the human retinoblastoma cell lines to invade the optic nerve and metastasize in orthotopic xenograft studies. However, the mechanisms that underlie these changes were not determined. We used the recently developed knockout mouse models of retinoblastoma to begin to characterize the molecular, cellular, and genetic changes associated with retinoblastoma tumor progression and optic nerve invasion. Here we report the isolation and characterization of the first mouse retinoblastoma cell lines with targeted deletions of the Rb family. Our detailed analysis of these cells as they were propagated in culture from the primary tumor shows that changes in cadherin-mediated cell adhesion are associated with retinoblastoma invasion of the optic nerve prior to metastasis. In addition, the same changes in cadherin-mediated cell adhesion correlate with the invasive properties of the human retinoblastoma cell lines isolated decades ago, providing a molecular mechanism for these earlier observations. Most importantly, our studies are in agreement with genetic studies on human retinoblastomas, suggesting that changes in this pathway are involved in tumor progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19786571      PMCID: PMC2786692          DOI: 10.1128/MCB.00374-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  31 in total

1.  Pax6 is required for the multipotent state of retinal progenitor cells.

Authors:  T Marquardt; R Ashery-Padan; N Andrejewski; R Scardigli; F Guillemot; P Gruss
Journal:  Cell       Date:  2001-04-06       Impact factor: 41.582

2.  Differential localization of SNARE complex proteins SNAP-25, syntaxin, and VAMP during development of the mammalian retina.

Authors:  M H Greenlee; C B Roosevelt; D S Sakaguchi
Journal:  J Comp Neurol       Date:  2001-02-12       Impact factor: 3.215

3.  ESR1 gene amplification in breast cancer: a common phenomenon?

Authors:  Hugo M Horlings; Anna Bergamaschi; Silje H Nordgard; Young H Kim; Wonshik Han; Dong-Young Noh; Keyan Salari; Simon A Joosse; Fabien Reyal; Ole Christian Lingjaerde; Vessela N Kristensen; Anne-Lise Børresen-Dale; Jonathan Pollack; Marc J van de Vijver
Journal:  Nat Genet       Date:  2008-07       Impact factor: 38.330

4.  Characteristics of an established cell line of retinoblastoma.

Authors:  T W Reid; D M Albert; A S Rabson; P Russell; J Craft; E W Chu; T S Tralka; J L Wilcox
Journal:  J Natl Cancer Inst       Date:  1974-08       Impact factor: 13.506

5.  Cadherin switching in human prostate cancer progression.

Authors:  K Tomita; A van Bokhoven; G J van Leenders; E T Ruijter; C F Jansen; M J Bussemakers; J A Schalken
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

6.  Structure and function of the N-cadherin/catenin complex in retinoblastoma.

Authors:  Elisabeth H Van Aken; Peggy Papeleu; Patrick De Potter; Erik Bruyneel; Jan Philippé; Stefan Seregard; Anders Kvanta; Jean-Jacques De Laey; Marc M Mareel
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-03       Impact factor: 4.799

Review 7.  Modelling the molecular circuitry of cancer.

Authors:  William C Hahn; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

8.  Minimal 16q genomic loss implicates cadherin-11 in retinoblastoma.

Authors:  Mellone N Marchong; Danian Chen; Timothy W Corson; Cheong Lee; Maria Harmandayan; Ella Bowles; Ning Chen; Brenda L Gallie
Journal:  Mol Cancer Res       Date:  2004-09       Impact factor: 5.852

9.  Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma.

Authors:  Danian Chen; Izhar Livne-bar; Jackie L Vanderluit; Ruth S Slack; Mahima Agochiya; Rod Bremner
Journal:  Cancer Cell       Date:  2004-06       Impact factor: 31.743

10.  Cell type-specific effects of Rb deletion in the murine retina.

Authors:  David MacPherson; Julien Sage; Teresa Kim; Dennis Ho; Margaret E McLaughlin; Tyler Jacks
Journal:  Genes Dev       Date:  2004-07-01       Impact factor: 11.361

View more
  18 in total

1.  A stapled p53 helix overcomes HDMX-mediated suppression of p53.

Authors:  Federico Bernal; Mark Wade; Marina Godes; Tina N Davis; David G Whitehead; Andrew L Kung; Geoffrey M Wahl; Loren D Walensky
Journal:  Cancer Cell       Date:  2010-11-16       Impact factor: 31.743

2.  Tumor-associated retinal astrocytes promote retinoblastoma cell proliferation through production of IGFBP-5.

Authors:  Xiaoliang L Xu; Thomas C Lee; Nneka Offor; Christine Cheng; Aihong Liu; Yuqiang Fang; Suresh C Jhanwar; David H Abramson; David Cobrinik
Journal:  Am J Pathol       Date:  2010-05-27       Impact factor: 4.307

3.  Silencing of RB1 but not of RB2/P130 induces cellular senescence and impairs the differentiation potential of human mesenchymal stem cells.

Authors:  Nicola Alessio; Wolfgang Bohn; Verena Rauchberger; Flavio Rizzolio; Marilena Cipollaro; Michael Rosemann; Martin Irmler; Johannes Beckers; Antonio Giordano; Umberto Galderisi
Journal:  Cell Mol Life Sci       Date:  2013-01-31       Impact factor: 9.261

4.  In vitro characterization of CD133lo cancer stem cells in Retinoblastoma Y79 cell line.

Authors:  Rohini M Nair; Murali Ms Balla; Imran Khan; Ravi Kiran Reddy Kalathur; Paturu Kondaiah; Geeta K Vemuganti
Journal:  BMC Cancer       Date:  2017-11-21       Impact factor: 4.430

5.  Diagnostic delay and sociodemographic predictors of stage at diagnosis and mortality in unilateral and bilateral retinoblastoma.

Authors:  Marco A Ramírez-Ortiz; M Veronica Ponce-Castañeda; M Lourdes Cabrera-Muñoz; Aurora Medina-Sansón; Xinhua Liu; Manuela A Orjuela
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-02-12       Impact factor: 4.254

Review 6.  The genomic landscape of retinoblastoma: a review.

Authors:  Brigitte L Thériault; Helen Dimaras; Brenda L Gallie; Timothy W Corson
Journal:  Clin Exp Ophthalmol       Date:  2013-05-22       Impact factor: 4.207

7.  Cdh11 acts as a tumor suppressor in a murine retinoblastoma model by facilitating tumor cell death.

Authors:  Mellone N Marchong; Christine Yurkowski; Clement Ma; Clarellen Spencer; Sanja Pajovic; Brenda L Gallie
Journal:  PLoS Genet       Date:  2010-04-22       Impact factor: 5.917

8.  Novel miRNA-31 and miRNA-200a-Mediated Regulation of Retinoblastoma Proliferation.

Authors:  Vanessa Montoya; Hanli Fan; Paul J Bryar; Joanna L Weinstein; Marilyn B Mets; Gang Feng; Joshua Martin; Alissa Martin; Hongmei Jiang; Nikia A Laurie
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

9.  Increased mitochondrial function downstream from KDM5A histone demethylase rescues differentiation in pRB-deficient cells.

Authors:  Renáta Váraljai; Abul B M M K Islam; Michael L Beshiri; Jalees Rehman; Nuria Lopez-Bigas; Elizaveta V Benevolenskaya
Journal:  Genes Dev       Date:  2015-08-27       Impact factor: 11.361

10.  Invasiveness and metastasis of retinoblastoma in an orthotopic zebrafish tumor model.

Authors:  Xiaoyun Chen; Jian Wang; Ziquan Cao; Kayoko Hosaka; Lasse Jensen; Huasheng Yang; Yuping Sun; Rujie Zhuang; Yizhi Liu; Yihai Cao
Journal:  Sci Rep       Date:  2015-07-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.